Success Story: Dual Success Despite RFE: Our Expert Team Helped a Japanese Associate Professor Receive EB1A and NIW Approvals
Client’s Testimonial:
“It has been our pleasure to work with you. Thank you for your support! Thank you so much again for your service.”
On April 23rd, 2025, and October 9th, 2024, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approvals for an Associate Professor in the Field of Urology (Approval Notice).
General Field: Urology
Position at the Time of Case Filing: Associate Professor
Country of Origin: Japan
Country of Residence at the Time of Filing: Japan
Approval Notice Date: October 9th, 2024 (EB1A) and April 23rd, 2025 (NIW)
Processing Time: 3 months, 22 days (EB1A - Premium Processing Requested), and 20 months, 23 days (NIW)
Case Summary:
In a remarkable demonstration of scientific excellence and strategic immigration planning, a distinguished associate professor in urology from Japan recently secured approval for both their I-140 EB1A (Alien of Extraordinary Ability) and I-140 NIW (National Interest Waiver) petitions. Both approvals followed successful responses to Requests for Evidence (RFEs), with the EB1A petition receiving Direct Premium Processing at the time of filing. The EB1A petition was approved in October 2024, and the NIW petition was approved in April 2025. We are proud to have supported this accomplished expert in navigating both pathways to permanent residence in the United States.
Advancing Urology through Genomic Research and Minimally Invasive Surgery
The petitioner is an established expert in urology, specializing in genomic research, kidney stone prevention and treatment, and the minimally invasive surgery of urinary stone disease. Their research focuses on critical areas such as understanding the function of macrophages in kidney stone production and dissolution, developing artificial intelligence-assisted navigation techniques for kidney stone surgery, investigating the genetic basis of urolithiasis, and evaluating the cost-effectiveness of ureteroscopy for stone treatments. This work addresses pressing global health issues related to urolithiasis and kidney stone formation, and the growing concern of obesity-related health problems.
The client plans to pursue employment as an adjunct assistant professor at a U.S. institution, where they will continue to conduct research on developing macrophage-based molecular therapies to prevent kidney stone development and creating artificial intelligence-powered surgical instruments to enhance procedural safety and precision.
Demonstrated Impact Across Both Petitions
In building both the EB1A and NIW cases, we presented a strong evidentiary record that confirmed the researcher’s standing as a leading authority in the urology community:
● A prolific publication record, including 104 peer-reviewed journal articles and 2 book chapters. ● An impressive citation count of 2194 with an h-index of 24, ranking them in the top 1.1% of authors in the field. Their work has been cited by researchers globally. ● Extensive peer review contributions, having conducted at least 93 reviews for prestigious journals and conferences, and serving on the editorial board of a highly discerning scientific journal, as well as currently serving as a guest associate editor for a special issue of a leading oncology journal.
The petitions were further strengthened by 8 compelling letters of recommendation from distinguished experts in the field of urology. One recommender noted:“[Client] occupies an important position within his field. His expertise and record of impactful research provide evidence that he is on track to continue to make substantial progress in his field in the near future. Without his presence, the research community of the United States would be at a distinct disadvantage.”
We are honored to have supported this gifted expert and look forward to their continued contributions to advancing urological research and enhancing healthcare outcomes in the United States and beyond.